Skip to main navigation Skip to main content Skip to page footer

STOPSTORM is the acronym for “Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant Tachycardia by a Multidisciplinary consortium.”

This project focuses on the treatment of patients with ventricular tachycardia – a potentially life-threatening rapid heart rhythm – using stereotactic radiotherapy. This non-invasive, high-precision technique, already established in the treatment of various cancers, is being investigated here as a novel therapeutic approach for refractory cardiac arrhythmias.

Project coordinator PD Dr. Oliver Blanck is positive about the future: “We hope to be able to provide new impulses for closer cooperation between two previously separate medical disciplines – radiation therapy and cardiology – for the joint treatment of refractory cardiac arrhythmias."

For Doctors   For Patients

News

Don't miss any updates! Here you'll find all the latest news about the StopStorm project:

In March 2025, the STOPSTORM Extended Management Board convened to review the current project status, align on key developments, and plan the upcoming…

Read more

In September 2024, the STOPSTORM consortium came together in Amsterdam for a major project meeting combined with the annual SNOSTORM meeting. With…

Read more

The Christian-Albrechts-University of Kiel (CAU) and the University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, have taken over the…

Read more

Check out this interesting interview with our External Advisory Board members Phillip Cuculich, MD and Clifford Robinson, MD. They explain their use…

Read more

We are happy to share that the STOPSTORM publication by Grehn & Mandija et al. is now available in #Europace! Current clinical cardiac radiotherapy…

Read more